Resultados de Procura por Autor :: APM

1

The Evolution of Therapies in Non-Small Cell Lung Cancer por Vishal Boolell, Muhammad Alamgeer, D. Neil Watkins, Vinod Ganju

Publicado 2015

Ligazón do recurso
Revisão

Engadir a favoritos

Gardado en:
2

Cancer stem cells in lung cancer: Evidence and controversies por Muhammad Alamgeer, Craig D. Peacock, William Matsui, Vinod Ganju, D. Neil Watkins

Publicado 2013

Ligazón do recurso Ligazón do recurso
Revisão

Engadir a favoritos

Gardado en:
3

Frailty and long-term survival among patients in Australian intensive care units with metastatic cancer (FRAIL-CANCER study): a retrospective registry-based cohort study por Muhammad Alamgeer, Ryan Ruiyang Ling, Ryo Ueno, Krishnaswamy Sundararajan, Raghav Sundar, David Pilcher, Ashwin Subramaniam

Publicado 2023

Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:
4

Changes in aldehyde dehydrogenase-1 expression during neoadjuvant chemotherapy predict outcome in locally advanced breast cancer por Muhammad Alamgeer, Vinod Ganju, Beena Kumar, Jane Fox, Stewart Hart, Michelle White, Marion Harris, John Stuckey, Zdenka Prodanovic, Michal Schneider, D. Neil Watkins

Publicado 2014

Ligazón do recurso Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:
5

The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer por Muhammad Alamgeer, Vinod Ganju, Anette Szczepny, Prudence A. Russell, Zdenka Prodanovic, Beena Kumar, Zoe Wainer, Tracey J. Brown, Michal Schneider, Matthew Conron, Gavin Wright, D. Neil Watkins

Publicado 2013

Ligazón do recurso Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:
6

Low-Dose Histone Deacetylase Inhibitor Treatment Leads to Tumor Growth Arrest and Multi-Lineage Differentiation of Malignant Rhabdoid Tumors por Andrea Muscat, Dean Popovski, W. Samantha N. Jayasekara, Fernando J. Rossello, Melissa Ferguson, Kieren D. Marini, Muhammad Alamgeer, Elizabeth M. Algar, Peter Downie, D. Neil Watkins, Jason E. Cain, David M. Ashley

Publicado 2016

Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:
7

MYC drives platinum resistant SCLC that is overcome by the dual PI3K-HDAC inhibitor fimepinostat por Jasmine Chen, Aleks C. Guanizo, W. Samantha N. Jakasekara, Chaitanya Inampudi, Quinton Luong, Daniel J. Garama, Muhammad Alamgeer, Nishant Thakur, Michael DeVeer, Vinod Ganju, D. Neil Watkins, Jason E. Cain, Daniel J. Gough

Publicado 2023

Ligazón do recurso Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:
8

Immune checkpoint inhibitor therapy for advanced cutaneous squamous cell carcinoma in Australia: a retrospective real world cohort study por Luke S. McLean, Annette M. Lim, Mathias Bressel, Jenny Lee, Rahul Ladwa, Alexander Guminski, Brett Hughes, Samantha Bowyer, Karen Briscoe, S.J. Harris, Craig Kukard, Robert Zielinski, Muhammad Alamgeer, Matteo S. Carlino, Jeremy Mo, John Park, Muhammad A. Khattak, Fiona Day, Danny Rischin

Publicado 2024

Ligazón do recurso Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:
9

Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy por Kieren D. Marini, David R. Croucher, Rachael A. McCloy, Vijesh Vaghjiani, Álvaro González-Rajal, Jordan F. Hastings, Venessa Chin, Anette Szczepny, Kaja Kostyrko, César Márquez, W. Samantha N. Jayasekara, Muhammad Alamgeer, Vishal Boolell, Jeremy Z. R. Han, Todd Waugh, Hong Ching Lee, Samantha R. Oakes, Beena Kumar, Craig A. Harrison, Mark P. Hedger, Nirmal Lorensuhewa, Badia Kita, Ross Barrow, Bruce Robinson, David M. de Kretser, Jianmin Wu, Vinod Ganju, E. Alejandro Sweet‐Cordero, Andrew Burgess, Luciano G. Martelotto, Fernando J. Rossello, Jason E. Cain, D. Neil Watkins

Publicado 2018

Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en: